Parathyroid Hormone-Related Changes of Bone Structure

Area of Science:

• Endocrinology
• Bone Metabolism
• Osteoporosis Research

Background:

• Parathyroid hormone (PTH) regulates calcium and phosphate, influencing bone resorption via osteoclasts and osteoblasts.
• Primary hyperparathyroidism (PHPT) can lead to skeletal and renal complications, with increasing prevalence of asymptomatic forms.
• Traditional fracture risk assessment may be insufficient, necessitating tools like Trabecular bone score (TBS).

Purpose of the Study:

• To evaluate the utility of Trabecular bone score (TBS) in assessing fracture risk in primary hyperparathyroidism (PHPT).
• To explore the relationship between TBS, bone mineral density (BMD), and high-resolution peripheral quantitative computed tomography (HR-pQCT) parameters in PHPT.
• To review the impact of PHPT treatment on TBS and bone microarchitecture.

Main Methods:

• Analysis of TBS in relation to vertebral fractures, BMD, age, BMI, and gender in PHPT patients.
• Correlation of TBS with HR-pQCT derived trabecular and cortical bone parameters.
• Review of studies investigating the effects of PHPT treatment and vitamin D supplementation on TBS.

Main Results:

• TBS is associated with vertebral fractures in PHPT, independent of BMD and other demographic factors.
• TBS correlates with HR-pQCT measures of bone microarchitecture in both trabecular and cortical compartments.
• Studies on TBS changes following PHPT treatment show conflicting results, while vitamin D deficiency-related hyperparathyroidism shows TBS improvement post-treatment.

Conclusions:

• Trabecular bone score (TBS) is a valuable tool for assessing fracture risk in primary hyperparathyroidism (PHPT), complementing BMD measurements.
• TBS provides insights into bone microarchitecture alterations in PHPT and secondary hyperparathyroidism due to vitamin D deficiency.
• Further research is needed to clarify the impact of PHPT treatment on TBS and long-term bone health.